# Regulation of CD20 in Rituximab-Resistant Cell Lines and B-cell Non-Hodgkin Lymphoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/regulation-of-cd20-in-rituximab-resistant-cell-lines-and-b-cell-non-hodgkin/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ping‐Chiao Tsai,Francisco J. Hernandez‐Ilizaliturri,Naveen Bangia,Scott H. Olejniczak,Myron S. Czuczman |
| Citations | 62 |
| DOI | 10.1158/1078-0432.ccr-11-1429 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2164073959 |
| PMID | 22228637 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Ping‐Chiao Tsai](https://scholariq.org/researchers/ping-chiao-tsai/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Paper topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.